Can Hyperbaric Oxygen Therapy Reduce Heart Damage? What a New Systematic Review Found
A new systematic review published in Cureus analyzed five clinical studies involving 431 patients to assess whether hyperbaric oxygen therapy (HBOT) can reduce markers of heart muscle damage and inflammation. The findings showed statistically significant reductions in several cardiac biomarkers, including a 35% drop in creatine phosphokinase (CPK) levels in one trial. Researchers also observed…